Anemia Market Research Reports

Anemia Market Research

Anemia, one of the more common blood disorders, occurs when the level of healthy red blood cells (RBCs) in the body reduces ... view more

RSS Sort By :
TITLE Price Buy Now More options

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Iron Deficiency Anemia – Pipeline Review, H1 2017, provides an overview of the Iron Deficiency Anemia (Hematological Disorders) pipeline landscape.Anemia is a cond...

$ 2000


Acquired (Autoimmune) Hemolytic Anemia Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Acquired (Autoimmune) Hemolytic Anemia Global Clinical Trials Review, H1, 2017" provides an overview...

$ 2500


DelveInsight “Sickle Cell Anemia - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Sickle Cell Anemia in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology histor...

$ 2750


DelveInsight’s Report, “Aplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the glob...

$ 2000


DelveInsight’s Report, “Congenital Hypoplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersa...

$ 2000


DelveInsight’s Report, “Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manuf...

$ 2000


DelveInsight’s Sickle Cell Anemia - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Sickle Cell Anemia for the seven major markets ie: United States, EU5 (France, Ger...

$ 4950


DelveInsight’s Report, “Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key...

$ 2000


DelveInsight’s Report, “Iron Deficiency Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross t...

$ 2000


DelveInsight’s Report, “Megaloblastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the...

$ 2000


DelveInsight’s Report, “Pernicious Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the gl...

$ 2000


DelveInsight’s Report, “Refractory Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the gl...

$ 2000


DelveInsight’s Report, “Renal Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. ...

$ 2000


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fanconi Anemia - Pipeline Review, H2 2016, provides an overview of the Fanconi Anemia (Hematological Disorders) pipeline landscape.Fanconi anemia (fan-KO-nee uh-NE...

$ 2000


Notes: Sales, means the sales volume of Anemia Drugs Revenue, means the sales value of Anemia Drugs This report studies sales (consumption) of Anemia Drugs in United States market, focuses on the top players, with sales, ...

$ 3800


Notes: Sales, means the sales volume of Aplastic Anemia Drug Revenue, means the sales value of Aplastic Anemia Drug This report studies sales (consumption) of Aplastic Anemia Drug in United States market, focuses on the t...

$ 3800


Notes: Sales, means the sales volume of Iron Deficiency Anemia Drug Revenue, means the sales value of Iron Deficiency Anemia Drug This report studies sales (consumption) of Iron Deficiency Anemia Drug in United States mar...

$ 3800


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia – Pipeline Review, H2 2016, provides an overview of the Aplastic Anemia (Hematological Disorders) pipeline landscape.Aplastic anemia is a syndrome ...

$ 2000


Notes: Sales, means the sales volume of Sickle Cell Anemia Drug Revenue, means the sales value of Sickle Cell Anemia Drug This report studies sales (consumption) of Sickle Cell Anemia Drug in United States market, focuses...

$ 3800


Notes: Sales, means the sales volume of Iron Deficiency Anemia Drug Revenue, means the sales value of Iron Deficiency Anemia Drug This report studies sales (consumption) of Iron Deficiency Anemia Drug in Global market, es...

$ 4000

Email Us
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: